Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Biol. Res ; 53: 28, 2020. graf
Artículo en Inglés | LILACS | ID: biblio-1124213

RESUMEN

BACKGROUND: Kidney ischemia-reperfusion injury is a common pathophysiological phenomenon in the clinic. A large number of studies have found that the tyrosine protein kinase/signal transducer and activator of transcription (JAK/STAT) pathway is involved in the development of a variety of kidney diseases and renal protection associated with multiple drugs. Edaravone (EDA) is an effective free radical scavenger that has been used clinically for the treatment of postischemic neuronal injury. This study aimed to identify whether EDA improved kidney function in rats with ischemia-reperfusion injury by regulating the JAK/STAT pathway and clarify the underlying mechanism. METHODS: Histomorphological analysis was used to assess pathological kidney injury, and mitochondrial damage was observed by transmission electron microscopy. Terminal deoxynucleotidyl transferase-mediated dUTP nick endlabeling (TUNEL) staining was performed to detect tubular epithelial cell apoptosis. The expression of JAK2, P-JAK2, STAT3, P-STAT3, STAT1, P-STAT1, BAX and Bcl-2 was assessed by western blotting. Mitochondrial function in the kidney was assessed by mitochondrial membrane potential (ΔψM) measurement. RESULTS: The results showed that EDA inhibited the expression of p-JAK2, p-STAT3 and p-STAT1, accompanied by downregulation of the expression of Bax and caspase-3, and significantly ameliorated kidney damage caused by ischemia-reperfusion injury (IRI). Furthermore, the JC-1 dye assay showed that edaravone attenuated ischemia-reperfusion-induced loss of kidney (ΔψM). CONCLUSION: Our findings indicate that EDA protects against kidney damage caused by ischemia-reperfusion through JAK/STAT signaling, inhibiting apoptosis and improving mitochondrial injury.


Asunto(s)
Animales , Masculino , Ratas , Daño por Reperfusión/tratamiento farmacológico , Depuradores de Radicales Libres/farmacología , Edaravona/farmacología , Transducción de Señal/efectos de los fármacos , Ratas Sprague-Dawley , Apoptosis , Factores de Transcripción STAT/efectos de los fármacos , Quinasas Janus/efectos de los fármacos , Mitocondrias
2.
Journal of Prevention and Treatment for Stomatological Diseases ; (12): 270-272, 2017.
Artículo en Chino | WPRIM | ID: wpr-822581

RESUMEN

@#Long-term stability is an important part of orthodontic treatment and wearing a retainer is one of the methods to keep stable after active orthodontic treatment. Transparent film retainer and Hawley retainer are two kinds of retainer usually used in clinical treatment. the previous one is easy to made, comfortable and beautiful to wear, easily damaged. Hawley retainer is relatively complex to made and in a large size. And it is durable and adjustable. However, there are differences between these retainers on the retaining effects in different types of malocclusion. In clinical treatment, according to the type of malocclusion, we choose the appropriate retainer to keep stable occlusal relationship after orthodontic treatment.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA